|
1.
|
Thom T, Haase N, Rosamond W, et al
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics - 2006
update: a report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
113:e85–e151. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Murphy SL, Xu JQ and Kochanek MA; Division
of Vital Statistics: Deaths: Preliminary data for 2010. National
Vital Statistics Reports. 60:1–68. 2012.
|
|
3.
|
He L, Tang X, Song Y, et al: Prevalence of
cardiovascular disease and risk factors in a rural district of
Beijing, China: a population-based survey of 58,308 residents. BMC
Public Health. 12:342012. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Nabel EG and Braunwald E: A tale of
coronary artery disease and myocardial infarction. N Eng J Med.
366:54–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Lenfant C: Chest pain of cardiac and
noncardiac origin. Metabolism. 59(Suppl 1): S41–S46. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Abrams J: Clinical practice. Chronic
stable angina. N Engl J Med. 352:2524–2533. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Barre J, Houin G, Brunner F, et al:
Disease-induced modifications of drug pharmacokinetics. Int J Clin
Pharmacol Res. 3:215–226. 1983.PubMed/NCBI
|
|
8.
|
Ventresca GP and Mariani L: Disease states
and changes in drug pharmacokinetics. Clin Ter. 47:131–144.
1996.(In Italian).
|
|
9.
|
Qin F, Huang X, Zhang HM and Ren P:
Pharmacokinetic comparison of puerarin after oral administration of
Jiawei-Xiaoyao-San in healthy volunteers and patients with
functional dyspepsia: influence of disease state. J Pharm
Pharmacol. 61:125–129. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Cho EJ, Yokozawa T and Okamoto T:
Protective effect of Chinese prescription Kangen-karyu and its
crude drug Tanjin against age-related lipidosis in rats. J Pharm
Pharmacol. 59:687–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Huang X, Qin F, Zhang HM, et al:
Cardioprotection by Guanxin II in rats with acute myocardial
infarction is related to its three compounds. J Ethnopharmacol.
121:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Qin F, Liu YX, Zhao HW, et al: Chinese
medicinal formula Guan-Xin-Er-Hao protects the heart against
oxidative stress induced by acute ischemic myocardial injury in
rats. Phytomedicine. 61:215–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Xu R, Huang X, Li Y, et al: Clinical
observation of treating coronary heart disease with
Guan-xin-er-hao. Journal of Chengdu University of Traditional
Chinese Medicine. 24(4): 17–19. 2001.(In Chinese).
|
|
14.
|
Zhao HW, Qin F, Liu YX, et al:
Antiapoptotic mechanisms of Chinese medicine formula
Guan-Xin-Er-Hao in the rat ischemic heart. Tohoku J Exp Med.
216:309–316. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zhao J, Huang X, Tang W, et al: Effect of
oriental herbal prescription Guan-Xin-Er-Hao on coronary flow in
healthy volunteers and antiapoptosis on myocardial
ischemia-reperfusion in rat models. Phytother Res. 21:926–931.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Qiao X, Han J, Xu M, et al:
Characterization of chemical constituents in Guan Xin II decoction
by liquid chromatography coupled with electrospray ionization-mass
spectrometry. Planta Med. 74:1720–1729. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wang Y, Huang X, Qin F, et al: A strategy
for detecting optimal ratio of cardioprotection-dependent three
compounds as quality control of guan-xin-er-hao formula. J
Ethnopharmacol. 133:735–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Guo GP, Ye Y, Li L, et al:
Endothelium-independent vasorelaxant effect of sodium ferulate on
rat thoracic aorta. Life Sci. 84:81–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Wang L, Wang Z, Wo S, et al: A
bio-activity guided in vitro pharmacokinetic method to improve the
quality control of Chinese medicines, application to Si Wu Tang.
Int J Pharm. 406:99–105. 2011. View Article : Google Scholar
|
|
20.
|
Qiu XJ, Huang X, Chen ZQ, et al:
Pharmacokinetic study of the prokinetic compounds meranzin hydrate
and ferulic acid following oral administration of Chaihu-Shugan-San
to patients with functional dyspepsia. J Ethnopharmacol.
137:205–213. 2011. View Article : Google Scholar
|
|
21.
|
Li Y, Liu C, Zhang Y, et al:
Pharmacokinetics of ferulic acid and potential interactions with
Honghua and clopidogrel in rats. J Ethnopharmacol. 137:562–567.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Li FQ, Xu S, Su H, et al: Development of a
gradient reversed-phase HPLC method for the determination of sodium
ferulate in beagle dog plasma. J Chromatogr B Analyt Technol Biomed
Life Sci. 846:319–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Li Y and Bi K: HPLC determination of
ferulic acid in rat plasma after oral administration of Rhizoma
Chuanxiong and its compound preparation. Biomed Chromatogr.
17:543–546. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Qi J, Jin X, Huang L and Ping Q:
Simultaneous determination of hydroxysafflor yellow A and ferulic
acid in rat plasma after oral administration of the co-extractum of
Rhizoma chuanxiong and Flos Carthami by HPLC-diode array
detector. Biomed Chromatogr. 21:816–822. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Yang C, Tian Y, Zhang Z, et al:
High-performance liquid chromatography-electrospray ionization mass
spectrometry determination of sodium ferulate in human plasma. J
Pharm Biomed Anal. 43:945–950. 2007. View Article : Google Scholar
|
|
26.
|
Kern P: Medical treatment of
echinococcosis under the guidance of Good Clinical Practice
(GCP/ICH). Parasitol Int. 55:S273–S282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Suzuki A, Yamamoto M, Jokura H, et al:
Ferulic acid restores endothelium-dependent vasodilation in aortas
of spontaneously hypertensive rats. Am J Hypertens. 20:508–513.
2007. View Article : Google Scholar
|
|
28.
|
Sullivan JM and Lobo RA: Considerations
for contraception in women with cardiovascular disorders. Am J
Obstet Gynecol. 168:2006–2011. 1993. View Article : Google Scholar : PubMed/NCBI
|
